CVS Health Co. (NYSE:CVS) Shares Sold by Wynn Capital LLC

Wynn Capital LLC cut its position in CVS Health Co. (NYSE:CVS) by 1.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 18,940 shares of the pharmacy operator’s stock after selling 215 shares during the quarter. Wynn Capital LLC’s holdings in CVS Health were worth $850,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. MidAtlantic Capital Management Inc. acquired a new position in CVS Health in the 3rd quarter valued at about $25,000. Livelsberger Financial Advisory acquired a new position in shares of CVS Health in the third quarter valued at approximately $31,000. Legacy Investment Solutions LLC purchased a new stake in CVS Health during the 3rd quarter worth approximately $31,000. Reston Wealth Management LLC acquired a new position in shares of CVS Health in the third quarter worth $32,000. Finally, Kathleen S. Wright Associates Inc. purchased a new stake in shares of CVS Health during the third quarter worth $33,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Stock Performance

Shares of NYSE CVS opened at $51.60 on Wednesday. The company has a 50-day simple moving average of $51.68 and a 200-day simple moving average of $56.44. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. The company has a market cap of $64.93 billion, a PE ratio of 13.10, a price-to-earnings-growth ratio of 0.85 and a beta of 0.59. CVS Health Co. has a 12 month low of $43.56 and a 12 month high of $80.75.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating the consensus estimate of $1.08 by $0.01. The company had revenue of $95.43 billion during the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. CVS Health’s revenue was up 6.3% on a year-over-year basis. During the same period in the previous year, the firm posted $2.21 EPS. On average, equities analysts anticipate that CVS Health Co. will post 5.32 earnings per share for the current year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd will be paid a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 5.16%. The ex-dividend date of this dividend is Thursday, January 23rd. CVS Health’s dividend payout ratio is currently 67.51%.

Analysts Set New Price Targets

Several equities research analysts have weighed in on CVS shares. Wells Fargo & Company upgraded CVS Health from an “equal weight” rating to an “overweight” rating and upped their price target for the stock from $60.00 to $66.00 in a report on Monday, November 18th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $62.00 target price on shares of CVS Health in a report on Tuesday, October 1st. TD Cowen lifted their price objective on shares of CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a research report on Monday, November 25th. Barclays dropped their price target on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a research note on Thursday, November 7th. Finally, Evercore ISI increased their target price on shares of CVS Health from $62.00 to $75.00 and gave the company an “outperform” rating in a research report on Tuesday, October 8th. One analyst has rated the stock with a sell rating, six have given a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat, CVS Health currently has a consensus rating of “Moderate Buy” and an average target price of $68.71.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.